abstract |
The invention relates to an antibody directed against galectin 9 and inhibitor of the suppressive activity of regulatory T lymphocytes, as well as the use of this antibody for the treatment of diseases associated with the suppressive activity of regulatory T lymphocytes, in particular the treatment cancer. |